Effectiveness of ramelteon for treatment of visual hallucinations in dementia with lewy bodies: A report of 4 cases

Journal of Clinical Psychopharmacology

Volumn 33, Issue 4, 2013, Pages 581-583

  Kasanuki, Koji ^a   Iseki, Eizo ^a   Nishida, Yoshiaki ^b   Fujishiro, Hiroshige ^a   Chiba, Yuhei ^a   Sato, Kiyoshi ^a   Arai, Heii ^b  

^a JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ARIPIPRAZOLE; DONEPEZIL; FLUORODEOXYGLUCOSE F 18; QUETIAPINE; RAMELTEON; TRAZODONE;

AGED; AGITATION; ANXIETY; BARTHEL INDEX; CAREGIVER BURDEN; CASE REPORT; COGNITIVE DEFECT; DIFFUSE LEWY BODY DISEASE; DISEASE DURATION; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; LETTER; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PITTSBURGH SLEEP QUALITY INDEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SLEEP DISORDER; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL HALLUCINATION;

AGED; AGED, 80 AND OVER; FEMALE; HALLUCINATIONS; HUMANS; HYPNOTICS AND SEDATIVES; INDENES; LEWY BODY DISEASE; MALE; PSYCHIATRIC STATUS RATING SCALES; REM SLEEP BEHAVIOR DISORDER; TREATMENT OUTCOME;

EID: 84879845875     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318295fdf4     Document Type: Letter

References (13)

1. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-1872.
2. Adi N, Mash DC, Ali Y, et al. Melatonin MT1 and MT2 receptor expression in Parkinson's disease. Med Sci Monit. 2010;16:BR61-BR67.
3. Dowling GA, Mastick J, Colling E, et al. Melatonin for sleep disturbance in Parkinson's disease. Sleep Med. 2005; 6:459-466.
4. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Westchester, IL; 2005: 148-152.
5. Gentili A, Weiner DK, Kuchibhatla M, et al. Test-retest reliability of the Pittsburgh Sleep Quality Index in nursing home residents. J Am Geriatr Soc. 1995; 43:1317-1318.
6. King AE, Mints J, Royall DR. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy bodyYrelated disorders. Mov Disord. 2011;26:1218-1224.
7. Perry RH, Irving D, Blessed G, et al. Dementia in old age: identification of a clinically and pathologically distinct disease category. Adv Neurol. 1990;51:41-46.
8. Mori T, Ikeda M, Fukuhara R, et al. Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB. Neurology. 2006;66:935-937.
9. Yamamoto R, Iseki E, Murayama N, et al. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies. J Neurol Sci. 2006;246: 95-101.
10. Espana RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep. 2011;34:845-858.
11. Pradol BM, Reiter RJ, Moral F. Perfusion of melatonin into the prefrontal cortex disrupts the circadian rhythm of acetylcholine but not or locomotor activity. J Pineal Res. 2003;35:283-287.
12. Appelbauma L, Wangc GX, Maro GS. Sleep-wake regulation and hypocretin-melatonin interaction in zebrafish. Proc Natl Acad Sci U S A. 2009;106:21942-21947.
13. Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain. 2007;130:1577-1585.